Immunity to tetanus, diphtheria and poliomyelitis in the adult population of Sweden in l991

International Journal of Epidemiology

Volumn 27, Issue 5, 1998, Pages 916-925

  Böttiger, Margareta ^a   Gustavsson, Olle ^b   Svensson, Åke ^c  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b County Medical Officer ^*  (Sweden)

^c STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Diphtheria; Immunity; Poliomyelitis; Serology; Tetanus; Vaccination

Indexed keywords

ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS VACCINE;

ADULT; HEALTH SURVEY; IMMUNITY; VACCINATION; VIRAL DISEASE;

ADULT; ARTICLE; BLOOD SAMPLING; DIPHTHERIA; FEMALE; HUMAN; IMMUNITY; MALE; NORMAL HUMAN; POLIOMYELITIS; PRIORITY JOURNAL; SEROLOGY; SWEDEN; TETANUS; TETANUS PROPHYLAXIS; VACCINATION;

ADULT; AGE FACTORS; DIPHTHERIA; FEMALE; HEALTH SURVEYS; HUMANS; IMMUNITY; MALE; POLIOMYELITIS; TETANUS; VACCINATION;

SWEDEN;

EID: 0031730013     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/27.5.916     Document Type: Article

References (50)

1. Svensson Å, Böttiger M, Gustavsson O. A study of immunity in the Swedish population: diphtheria, tetanus, and poliomyelitis. Int J Epidemicl 1998:27:907-13.
2. Hulten O. Om tetanusfrekvens och tetanusmortalitet. Nord Med 1962;68:1322.
3. Eriksson E, Ullberg-Olsson K, Källen B, Ehinger B, Diamant H. God prognos vid tetanus med intensiv behandling. Läkartidningm 1980:77:3591-92.
4. Christenson B, Böttiger M. Epidemiology and immunity to tetanus in Sweden. Scand J Infect Dis 1987;19:429-35.
5. Eriksson H, Adamsson C-A, Eriksson B. Aktiv immunisering mot stelkramp jämte immunologiska studier av stelkrampsprofylax. Sv Läkartidningen 1944;41:1805-19.
6. Eriksson H. Studies on tetanus prophylaxis. J Clin Path 1948;1:306-10.
7. Socialstyrelsens allmänna räd om profylax mot difteri och stclkramp (SoSFS 1990:21)
8. Björkholm B, Oiling S, Larsson P, Hagberg L. An outbreak of diphtheria among Swedish alcoholics. Infection 1987:15:354-58.
9. Christenson B, Hellström L, Aust-Kettis A, Erfarenheter av difterifall i Stockholm vären 1986. Läkartidningen 1988;85:1147-19.
10. Ericsson H. Alunfällt difteriantitoxin, dess framställning for aktiv immunisering mot difteri. Nordisk Median 1942;16:3569.
11. Ericsson H. Purification and adsorbtion of diphtheria toxoid. Nature 1946;158:350.
12. Ericsson H, Ericsson B. Erfarenheter av massympningar mot difteri i Sverige. Nordisk Median 1946;32:2528-32.
13. Ericsson H, Wahlquist B, Hesselvik L. Combined immunization against diphtheria, tetanus and pertussis in infancy. Acta Ped Scand 1954:43:15.
14. Böttiger M, Zetterberg B, Salenstedt C-R. Seroimmunity to poliomyelitis in Sweden after the use of inactivated poliovirus vaccine for 10 years. Bull World Health Organ 1972:46:141-49.
15. Rabo E, Salenstedt R. Difterivaccinering med tetanusvaccin med tillsats av difteritoxoid. Läkartidningen 1970:67:5344-45.
16. Bergenholz NA. Rapport 830. Riksarkivet, Medicinalstyrelsen, Äldre 1878-1914. Sjukreserapporter E 11, vol 6.
17. Olin G. The epidemiologic pattern of poliomyelitis in Sweden from 1905 to 1950. Second International Poliomyelitis Conference, JB Lippincott Co, 1952, pp.367-75.
18. Olin G, Wesslén T. Seroimmune patterns for poliomyelitis in Sweden. Archiv gesamte Virusforschung 1957;7:191-205.
19. Böttiger M, Zetterberg B, Salenstedt C-R. Seroimmunity to poliomyelitis in Sweden after the use of inactivated poliovirus vaccine for 10 years. Bull World Health Organ 1972;46:141-49.
20. Böttiger M, Mellin P, Romanus V, Söderström T, Wesslén T, von Zeipel G. Epidemiological events surrounding a paralytic case of poliomyelitis in Sweden. Bull World Health Organ 1979;57:99-103.
21. Gard S. Poliovaccination and epidemiologic situation in Scandinavia. 10th Symposium of European Association for Poliomyelitis and Allied Diseases, Warsaw 1964. Proceedings, 10, pp.111-3.
22. Global eradication of poliomyelitis in the year 2000. In the Forty-first World Health Assembly, Geneva, 2-13 May 1988: Resolutions and Decisions Annexes (Resolution WHA 41.28). Geneva: World Health Organization, 1988, p.26.
23. Böttiger M, Larsson B. Swedish inactivated poliovacdne: Laboratory standardization and clinical experience over a 30-year period. Biologicals 1992:20:267-75.
24. Onorato IM, Modlin JF, McBean AM, Thorns ML, Losonsky GA, Bernin R. Mucosal immunity induced by enhanced-potency inactivated and oral polio vaccines. J Infect Dis 1991;163:l-6.
25. Böttiger M. A study of the seroimmunity that has protected the Swedish population against poliomyelitis for 25 years. Scand J Infect Dis 1987;19;595-601.
26. Simonsen O, Bentzon MW, Heron I. ELISA for the routine determination of antitoxic immunity to tetanus. J Biol Standard 1986;14:231-39.
27. Simonsen O, Schou C, Heron I. Modification of the ELISA for the estimation of tetanus antitoxin in human sera. J Biol Standard 1987; 15:143-57.
28. Hendriksen CFM, v.d. Gun JW, Nagel J, Kreeftenberg JG. The toxin binding inhibition test as a reliable in vitro alternative to the toxin neutralization test in mice for the estimation of tetanus antitoxin in human sera. J Biol Standard 1988;16:287-97.
29. Scheibel I. The uses and results of active tetanus immunization. Bull World Health Organ 1955;13:381-94.
30. Christenson B, Böttiger M. Serological immunity to diphtheria in Sweden in 1978 and 1984. Scand J Infect Dis 1986:18:227-33.
31. Miyamura K, Nishio S, Ito A, Murata R, Kono R. Micro cell culture method for determination of diphtheria toxin and antitoxin titers using VERO cells. I. Studies of factors affecting the toxin and antitoxin titration. J Biol Stand 1974:2:189-201.
32. Miyamura K, Tajiri E, Ito A, Murata R, Kono R. Micro cell culture method for determination of diphtheria toxin and antitoxin using VERO cells. II. Comparison with rabbit skin method and practical application for sero-epidemiological studies. J Biol Stand 1974;2:203-09.
33. Griffith AH. The role of immunization in the control of diphtheria. Dev Biol Stand 1979;43:3-13.
34. Ipsen J. Circulating antitoxin at the onset of diphtheria in 425 patients, Immunol 1946;54:325-447.
35. Report of a collaborative study on poliovirus antibody titrations. Forum for the Advancement of Immunization Research (FAIR), 5, Boulevard du Montparnasse, 75006 Paris, France. 20 November 1981.
36. Gergen PJ, McQuillan GM, Kiely M, Ezzati-Rice TM, Sutter RW, Virella G. A population-based serologie survey of immunity to tetanus in the United States. N Engl J Med 1995;332:761-66.
37. Cilia G, Saenz-Dominiguez JR. Montes M, Part C, Perez-Trallero E. Immunidad frente al tetanos en adultos mayores de 49 anos. [Immunity against tetanus in adults over the age of 49 years]. Med Clin (Bare) 1994;103:571-73.
38. Rix BA, Zhobakas A, Wachmann CH, Bakasenas V, Ronne T. Immunity from diphtheria, tetanus, poliomyelitis, measles, mumps and rubella among adults in Lithuania. Scand J Infect Dis 1994;26:459-67.
39. UlIberg-Olsson K, Eriksson E. Active immunization against tetanus in man. I Duration of anamnestic reaction after one dose of vaccine. Eur Surg Res 1975;7:249-58.
40. Expanded programme on immunization. Diphtheria epidemic in the newly independent states of the former USSR, 1990-1994. Weekly Epidemiol Rec 1995:70:141-47.
41. Böttiger M. Antibody stimulation in individuals without demonstrable polio virus antibodies following a fifth injection of inactivated poliovirus vaccine. Acta Path Microbiol Scand Section B 1973;81:795-98.
42. Böttiger M. Neutralizing capacity of poliovirus type 3 antibodies tested against 5 different intratypic variants of poliovirus type 3. Archiv Gesamte Virusforschung 1971;35:251-55.
43. Hovi T, Cantell K, Houvilainen A et al. Outbreak of paralytic poliomyelitis in Finland: widespread circulation of antigenically altered poliovirus type 3 in a vaccinated population. Lancet 1986;ii:1427-32.
44. Böttiger M. Polio immunity to killed vaccine: An 18-year follow-up. Vaccine 1990:8:443-45.
45. McBean AM, Thorns ML, Albrecht P, Cuthie JC, Bernier R. Serologie response to oral polio vaccine and enhanced-potency inactivated polio vaccines. Am J Epidemiol 1987:128:615-28.
46. Salk J, van Wezel AL, Stoeckel P et al. Theoretical and practical considerations in the application of killed poliovirus vaccine for the control of parlytic poliomyelitis. International Symposium on Reassessment of Inactivated Poliomyelitis Vaccine. Bilthoven 1980. Develop Biol Standard, pp.181-198. (S. Kager, Basel 1981)
47. WHO. Report of the 1st meeting of the Global Commission for the Certification of the Eradication of Poliomyelitis. Expanded Programme on Immunization, Global Programme for Vaccines and Imrnunization, 16-17 February 1995.
48. Diedrich S, Schreier E. Immunitetslage gegen Poliomyelitis. PolioSeros urveillance 1993. Deutsch Med Wochenschr 1995:120:239-44.
49. Trivello R, Farisano G, Bonello G et al. Immunity status to poliovirus in Vento region (north-east Italy). A seroepidemiological survey. Ann Clin Lab Sci I994;24:542-47.
50. Pan-American Health Organization. Weekly poliovirus bulletin. Vol. 9. Washington DC: Pan-American Health Organization, 20 August 1994.